181 related articles for article (PubMed ID: 35213534)
21. A review of biomedical datasets relating to drug discovery: a knowledge graph perspective.
Bonner S; Barrett IP; Ye C; Swiers R; Engkvist O; Bender A; Hoyt CT; Hamilton WL
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36151740
[TBL] [Abstract][Full Text] [Related]
22. Ensembles of knowledge graph embedding models improve predictions for drug discovery.
Rivas-Barragan D; Domingo-Fernández D; Gadiya Y; Healey D
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36384050
[TBL] [Abstract][Full Text] [Related]
23. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
Lee SY; Song MY; Kim D; Park C; Park DK; Kim DG; Yoo JS; Kim YH
Front Pharmacol; 2019; 10():1653. PubMed ID: 32063857
[TBL] [Abstract][Full Text] [Related]
24. Drug target prediction and repositioning using an integrated network-based approach.
Emig D; Ivliev A; Pustovalova O; Lancashire L; Bureeva S; Nikolsky Y; Bessarabova M
PLoS One; 2013; 8(4):e60618. PubMed ID: 23593264
[TBL] [Abstract][Full Text] [Related]
25. Elucidating the semantics-topology trade-off for knowledge inference-based pharmacological discovery.
Sosa DN; Neculae G; Fauqueur J; Altman RB
J Biomed Semantics; 2024 May; 15(1):5. PubMed ID: 38693563
[TBL] [Abstract][Full Text] [Related]
26. Drug repositioning based on the heterogeneous information fusion graph convolutional network.
Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011
[TBL] [Abstract][Full Text] [Related]
27. Signature-based approaches for informed drug repurposing: targeting CNS disorders.
Shukla R; Henkel ND; Alganem K; Hamoud AR; Reigle J; Alnafisah RS; Eby HM; Imami AS; Creeden JF; Miruzzi SA; Meller J; Mccullumsmith RE
Neuropsychopharmacology; 2021 Jan; 46(1):116-130. PubMed ID: 32604402
[TBL] [Abstract][Full Text] [Related]
28. Identifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering.
Wang F; Ding Y; Lei X; Liao B; Wu FX
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):953-965. PubMed ID: 32845842
[TBL] [Abstract][Full Text] [Related]
29. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
[TBL] [Abstract][Full Text] [Related]
30. Knowledge graph analytics platform with LINCS and IDG for Parkinson's disease target illumination.
Yang JJ; Gessner CR; Duerksen JL; Biber D; Binder JL; Ozturk M; Foote B; McEntire R; Stirling K; Ding Y; Wild DJ
BMC Bioinformatics; 2022 Jan; 23(1):37. PubMed ID: 35021991
[TBL] [Abstract][Full Text] [Related]
31. Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding.
Islam MK; Amaya-Ramirez D; Maigret B; Devignes MD; Aridhi S; Smaïl-Tabbone M
Sci Rep; 2023 Mar; 13(1):3643. PubMed ID: 36871056
[TBL] [Abstract][Full Text] [Related]
32. Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration.
Wu G; Liu J; Wang C
BMC Med Genomics; 2017 Dec; 10(Suppl 5):79. PubMed ID: 29297383
[TBL] [Abstract][Full Text] [Related]
33. Drug repurposing and prediction of multiple interaction types via graph embedding.
Amiri Souri E; Chenoweth A; Karagiannis SN; Tsoka S
BMC Bioinformatics; 2023 May; 24(1):202. PubMed ID: 37193964
[TBL] [Abstract][Full Text] [Related]
34. Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities.
Shah I; Bundy J; Chambers B; Everett LJ; Haggard D; Harrill J; Judson RS; Nyffeler J; Patlewicz G
Chem Res Toxicol; 2022 Nov; 35(11):1929-1949. PubMed ID: 36301716
[TBL] [Abstract][Full Text] [Related]
35. Drug repurposing: Iron in the fire for older drugs.
Sonaye HV; Sheikh RY; Doifode CA
Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
[TBL] [Abstract][Full Text] [Related]
36. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
37. Computational Methods for Drug Repurposing.
Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
[TBL] [Abstract][Full Text] [Related]
38. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
[TBL] [Abstract][Full Text] [Related]
39. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Jang D; Lee S; Lee J; Kim K; Lee D
J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
[TBL] [Abstract][Full Text] [Related]
40. GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing.
Zhang F; Hu W; Liu Y
BMC Bioinformatics; 2022 Sep; 23(1):372. PubMed ID: 36100897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
